Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The oral disposition index calculated from a meal tolerance test is a crucial indicator for evaluating differential normalization of postprandial glucose and triglyceride excursions in morbidly obese patients after laparoscopic sleeve gastrectomy.
Yamamoto Y, Togawa T, Sekine O, Ozamoto Y, Fuse J, Azuma C, Ito-Kobayashi J, Oe Y, Hagiwara A, Kobayashi M, Kitamura T, Iwanishi M, Shimatsu A, Kashiwagi A. Yamamoto Y, et al. Among authors: shimatsu a. Endocr J. 2023 Dec 28;70(12):1141-1157. doi: 10.1507/endocrj.EJ23-0241. Epub 2023 Oct 17. Endocr J. 2023. PMID: 37853621 Free article.
Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease.
Pivonello R, Fleseriu M, Newell-Price J, Shimatsu A, Feelders RA, Kadioglu P, Tabarin A, Brue TC, Geer EB, Piacentini A, Pedroncelli AM, Biller BMK. Pivonello R, et al. Among authors: shimatsu a. J Endocrinol Invest. 2024 May 2. doi: 10.1007/s40618-024-02359-6. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38696122
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension.
Fleseriu M, Newell-Price J, Pivonello R, Shimatsu A, Auchus RJ, Scaroni C, Belaya Z, Feelders RA, Vila G, Houde G, Walia R, Izquierdo M, Roughton M, Pedroncelli AM, Biller BMK. Fleseriu M, et al. Among authors: shimatsu a. Eur J Endocrinol. 2022 Sep 16;187(4):531-541. doi: 10.1530/EJE-22-0317. Print 2022 Oct 1. Eur J Endocrinol. 2022. PMID: 35980235 Free PMC article.
Clearance of macro-TSH from the circulation is slower than TSH.
Yamada A, Hattori N, Matsuda T, Nishiyama N, Shimatsu A. Yamada A, et al. Among authors: shimatsu a. Clin Chem Lab Med. 2022 Mar 14;60(6):e132-e135. doi: 10.1515/cclm-2022-0131. Print 2022 May 25. Clin Chem Lab Med. 2022. PMID: 35285221 No abstract available.
360 results